Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Draft guidance proposals from industry allowed under FDA "good guidance practices" policy.

This article was originally published in The Gray Sheet

Executive Summary

DRAFT GUIDANCE PROPOSALS BY INDUSTRY TO FDA PERMITTED under the agency's "good guidance practices" policy published in Feb. 27 Federal Register. The GGP includes a "guidance proposal policy" whereby the public will have "an opportunity to propose topics for new or revised guidance or to propose draft guidance documents." FDA says it is allowing members of the public to propose guidance to encourage input during the guidance development and revision process.
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT007615

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel